CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

167 hedge funds and large institutions have $2.15B invested in Celldex Therapeutics in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 17 closing their positions.

Holders
167
Holders Change
+9
Holders Change %
+5.7%
% of All Funds
2.69%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
27
Increased
50
Reduced
57
Closed
17
Calls
$35.1M
Puts
$17.1M
Net Calls
+$18M
Net Calls Change
+$6.66M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$207M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$22.5M
3
Jennison Associates
3
Jennison Associates
New York
$69.3M
4
TCMG
4
TSP Capital Management Group
New Jersey
$12M
5
PCH
5
Polar Capital Holdings
United Kingdom
$69.1M

Top Sellers

1
State Street
1
State Street
Massachusetts
$102M
2
Citadel Advisors
2
Citadel Advisors
Florida
$33.9M
3
EAM
3
Eventide Asset Management
Massachusetts
$65.2M
4
Goldman Sachs
4
Goldman Sachs
New York
$20M
5
ACP
5
Acuta Capital Partners
California
$5.13M
Name Holding Trade Value Shares
Change 		Shares
Change %
GCP
176
GSA Capital Partners
United Kingdom
– -$312K -11,116 Closed
First Trust Advisors
177
First Trust Advisors
Illinois
– -$292K -10,399 Closed
BCM
178
Bayesian Capital Management
New York
– -$222K -7,911 Closed
DFCM
179
Dark Forest Capital Management
Puerto Rico
– -$98K -3,492 Closed
ACA
180
Atlas Capital Advisors
Wyoming
– -$75.9K -2,700 Closed
Macquarie Group
181
Macquarie Group
Australia
– -$26K – –
4 5 6 7
8